Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04342884 · ClinicalTrials.gov registry record
COVID-19 Community Research Partnership
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 61,410
- Enrollment target
NCT04342884: Completed study, sponsored by Wake Forest University Health Sciences.
NCT04342884 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 61,410 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04342884 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 61,410 participants
- Enrollment target
Study Summary
The purpose of this research is to collect information about the North Carolina community's coronavirus exposures, symptoms, and health care visits due to the virus. Participation in this study will involve completing a daily questionnaire which covers participants coronavirus illness history or symptoms, health care seeking behaviors and treatments, contact with other sick people, and for health care workers, their use of personal protective equipment.
Primary Outcome
Percent of volunteers who are 2019-nCoV Ab test positive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61,410 participants |
| Start Date | 2020-04-08 |
| Est. Completion | 2022-05-02 |
What the finished NCT04342884 record still lists
NCT04342884 is an observational study that tracks outcomes without assigning an intervention. Its 61,410 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04342884 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04342884 about?
NCT04342884 is a clinical study titled "COVID-19 Community Research Partnership". The purpose of this research is to collect information about the North Carolina community's coronavirus exposures, symptoms, and health care visits due to the virus. Participation in this study will involve completing a daily questionnaire which covers participants coronavirus illness history or sym...
What is the current status of trial NCT04342884?
This trial is currently completed. The enrollment target is 61,410 participants. The study started on 2020-04-08. Estimated completion is 2022-05-02.
Who is sponsoring clinical trial NCT04342884?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05723614 · 61,770 participants · NA
TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven
- NCT03752840 · 60,200 participants · NA
Village-Integrated Eye Worker Trial II
- NCT00785525 · 60,000 participants · Phase 3
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
- NCT01825499 · 60,000 participants
Vermont Oxford Network Very Low Birth Weight Database
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI